- Filed
- Aug 13, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2021 · Aug 13, 2021 | 9.25M sh |
| Shares Diluted | Q2 2021 · Jun 30, 2021 | 9.26M sh |
| Shares Diluted | Q2 2021 · Jun 30, 2021 | 9.26M sh |
| Shares Diluted | Q2 2021 · Jun 30, 2020 | 9.62M sh |
| Shares Diluted | Q2 2021 · Jun 30, 2020 | 9.65M sh |
| Dividends Paid | Q2 2021 · Jun 30, 2021 | $462.5K |
| Dividends Paid | Q2 2021 · Jun 30, 2020 | $694.15K |
| Capex | Q2 2021 · Jun 30, 2021 | $466.26K |
| Capex restated | Q2 2021 · Jun 30, 2020 | $312.28K |
| Operating Cash Flow | Q2 2021 · Jun 30, 2021 | $8.1M |
| Operating Cash Flow restated | Q2 2021 · Jun 30, 2020 | $13.75M |
| Long Term Debt | Q2 2021 · Jun 30, 2021 | $2M |
| Long Term Debt | Q2 2021 · Dec 31, 2020 | $3.11M |
| Short Term Investments | Q2 2021 · Jun 30, 2021 | $35.58M |
| Short Term Investments | Q2 2021 · Dec 31, 2020 | $17.09M |
| Cash And Equivalents | Q2 2021 · Jun 30, 2021 | $19.93M |
| Cash And Equivalents | Q2 2021 · Dec 31, 2020 | $32.5M |
| Cash And Equivalents restated | Q2 2021 · Jun 30, 2020 | $25.53M |
| Cash And Equivalents restated | Q2 2021 · Dec 31, 2019 | $27.16M |
| Stockholders Equity | Q2 2021 · Jun 30, 2021 | $75.88M |
| Stockholders Equity | Q2 2021 · Dec 31, 2020 | $68.03M |
| Current Liabilities | Q2 2021 · Jun 30, 2021 | $19.07M |
| Current Liabilities | Q2 2021 · Dec 31, 2020 | $19.22M |
| Total Liabilities | Q2 2021 · Jun 30, 2021 | $33.22M |
| Total Liabilities | Q2 2021 · Dec 31, 2020 | $33.55M |
| Current Assets | Q2 2021 · Jun 30, 2021 | $75.02M |
| Current Assets | Q2 2021 · Dec 31, 2020 | $68.15M |
| Total Assets | Q2 2021 · Jun 30, 2021 | $110.94M |
| Total Assets | Q2 2021 · Dec 31, 2020 | $103.14M |
| Total Assets restated | Q2 2021 · Jun 30, 2020 | $107.68M |
| Eps Diluted | Q2 2021 · Jun 30, 2021 | $0.47 |
| Eps Diluted | Q2 2021 · Jun 30, 2021 | $0.90 |
| Eps Diluted | Q2 2021 · Jun 30, 2020 | $0.53 |
| Eps Diluted | Q2 2021 · Jun 30, 2020 | $0.70 |
| Eps Basic | Q2 2021 · Jun 30, 2021 | $0.48 |
| Eps Basic | Q2 2021 · Jun 30, 2021 | $0.90 |
| Eps Basic | Q2 2021 · Jun 30, 2020 | $0.53 |
| Eps Basic | Q2 2021 · Jun 30, 2020 | $0.70 |
| Sga Expense | Q2 2021 · Jun 30, 2021 | $2.34M |
| Sga Expense | Q2 2021 · Jun 30, 2021 | $4.79M |
| Sga Expense restated | Q2 2021 · Jun 30, 2020 | $3.59M |
| Sga Expense restated | Q2 2021 · Jun 30, 2020 | $6.15M |
| Operating Income | Q2 2021 · Jun 30, 2021 | $6.53M |
| Operating Income | Q2 2021 · Jun 30, 2021 | $12.5M |
| Operating Income restated | Q2 2021 · Jun 30, 2020 | $7.14M |
| Operating Income restated | Q2 2021 · Jun 30, 2020 | $9.82M |
| Gross Profit | Q2 2021 · Jun 30, 2021 | $22.69M |
| Gross Profit | Q2 2021 · Jun 30, 2021 | $45.56M |
| Gross Profit restated | Q2 2021 · Jun 30, 2020 | $24.51M |
| Gross Profit restated | Q2 2021 · Jun 30, 2020 | $44.33M |
| Cost Of Revenue | Q2 2021 · Jun 30, 2021 | $21.21M |
| Cost Of Revenue | Q2 2021 · Jun 30, 2021 | $42.53M |
| Cost Of Revenue restated | Q2 2021 · Jun 30, 2020 | $21.28M |
| Cost Of Revenue restated | Q2 2021 · Jun 30, 2020 | $37.1M |
| Revenue | Q2 2021 · Jun 30, 2021 | $43.03M |
| Revenue | Q2 2021 · Jun 30, 2021 | $86.21M |
| Revenue | Q2 2021 · Jun 30, 2020 | $44.61M |
| Revenue | Q2 2021 · Jun 30, 2020 | $78.22M |